🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/10/1978 | 1,55 | 1,57 | 1,54 | 1,54 | -0,43% | 1,72% | 1.124.294 |
| 05/10/1978 | 1,58 | 1,58 | 1,55 | 1,55 | -1,68% | 1,68% | 1.844.899 |
| 04/10/1978 | 1,58 | 1,59 | 1,55 | 1,58 | -0,21% | 2,09% | 1.505.347 |
| 03/10/1978 | 1,60 | 1,60 | 1,58 | 1,58 | -1,04% | 1,04% | 1.569.485 |
| 02/10/1978 | 1,59 | 1,63 | 1,58 | 1,60 | +0,42% | 2,92% | 3.176.698 |
| 29/09/1978 | 1,58 | 1,59 | 1,58 | 1,59 | +0,84% | 0,84% | 2.059.949 |
| 28/09/1978 | 1,56 | 1,58 | 1,55 | 1,58 | +1,28% | 1,70% | 1.312.934 |
| 27/09/1978 | 1,58 | 1,60 | 1,55 | 1,56 | -1,67% | 2,93% | 1.867.536 |
| 26/09/1978 | 1,59 | 1,59 | 1,58 | 1,58 | -0,42% | 0,83% | 1.629.850 |
| 25/09/1978 | 1,60 | 1,60 | 1,57 | 1,59 | -1,03% | 1,86% | 1.245.024 |
| 22/09/1978 | 1,61 | 1,63 | 1,60 | 1,61 | -0,20% | 2,06% | 2.410.819 |
| 21/09/1978 | 1,63 | 1,63 | 1,60 | 1,61 | -1,22% | 2,23% | 3.644.525 |
| 20/09/1978 | 1,65 | 1,66 | 1,62 | 1,63 | -1,21% | 2,21% | 1.626.077 |
| 19/09/1978 | 1,64 | 1,67 | 1,64 | 1,65 | +0,81% | 1,82% | 1.512.893 |
| 18/09/1978 | 1,63 | 1,65 | 1,62 | 1,64 | +0,20% | 2,03% | 2.505.139 |
| 15/09/1978 | 1,64 | 1,65 | 1,62 | 1,63 | -0,20% | 1,63% | 2.418.365 |
| 14/09/1978 | 1,66 | 1,66 | 1,64 | 1,64 | -2,18% | 1,59% | 2.018.448 |
| 13/09/1978 | 1,72 | 1,74 | 1,67 | 1,67 | -2,88% | 3,85% | 1.629.850 |
| 12/09/1978 | 1,74 | 1,74 | 1,71 | 1,72 | -1,14% | 1,34% | 1.931.674 |
| 11/09/1978 | 1,74 | 1,76 | 1,74 | 1,74 | +0,76% | 1,14% | 3.482.294 |
| 08/09/1978 | 1,71 | 1,73 | 1,71 | 1,73 | +1,36% | 1,36% | 2.686.234 |
| 07/09/1978 | 1,68 | 1,71 | 1,67 | 1,71 | +1,78% | 1,97% | 7.783.286 |
| 06/09/1978 | 1,66 | 1,68 | 1,66 | 1,68 | +1,61% | 1,60% | 4.334.947 |
| 05/09/1978 | 1,63 | 1,65 | 1,63 | 1,65 | +1,63% | 1,22% | 1.954.310 |
| 01/09/1978 | 1,61 | 1,63 | 1,60 | 1,62 | +0,83% | 1,65% | 2.727.734 |
| 31/08/1978 | 1,58 | 1,61 | 1,57 | 1,61 | +1,89% | 2,51% | 2.927.693 |
| 30/08/1978 | 1,58 | 1,59 | 1,56 | 1,58 | +0,21% | 1,47% | 1.565.712 |
| 29/08/1978 | 1,57 | 1,59 | 1,57 | 1,58 | +0,42% | 1,05% | 2.354.227 |
| 28/08/1978 | 1,58 | 1,58 | 1,56 | 1,57 | -2,06% | 1,26% | 1.569.485 |
| 25/08/1978 | 1,61 | 1,61 | 1,59 | 1,60 | -0,61% | 1,03% | 1.418.573 |